![montes archimedes acquisition corp montes archimedes acquisition corp](https://sec.report/Document/0001104659-21-085475/tm2119232d5_ex99-1img030.jpg)
To receive more information regarding the investigation of Montes Archimedes Acquisition Corp. Under the terms of the agreement, MAAC will acquire Roivant through a reverse merger, with Roivant emerging as a publicly traded company. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify, acquire and manage a business or businesses that can benefit from our management team’s established global relationships and operating experience. (MAAC) relating to its proposed merger with Roivant Sciences. in each case, with copies to: Kirkland & Ellis LLP 601 Lexington Avenue New York, New York 10022 Attn: Christian Nagler, Esq. 724 Oak Grove Menlo Park, CA 94025 Attn: Maria C. Our efforts to identify a potential initial business combination target will not be limited to a specific industry, sector or geographic region. if to the Company, to: Montes Archimedes Acquisition Corp.
![montes archimedes acquisition corp montes archimedes acquisition corp](https://pe-insider.com/wp-content/uploads/2021/05/Vivek-Ramaswamy-scaled-1300x731.jpg)
We have not identified any potential business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any potential business combination target. Montes Archimedes Acquisition Corp.We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology Roivant Sciences and Montes Archimedes Acquisition Corp. and certain other persons party theretoįorm of Subscription Agreement (incorporated herein by reference to Exhibit 10.2 of Montes Archimedes Acquisition Corp.’s Current Report on Form 8-K, filed with the SEC on May 1, 2021)īusiness Combination Agreement, dated as of May 1, 2021, by and among Montes Archimedes Acquisition Corp, Roivant Sciences Ltd. Sponsor Support Agreement, dated as of May 1, 2021, by and among Patient Square Capital LLC, Montes Archimedes Acquisition Corp, Roivant Sciences Ltd. 1 to the Business Combination Agreement, dated as of June 9, 2021, by and among Montes Archimedes Acquisition Corp, Roivant Sciences Ltd. and certain other persons party thereto.Īmendment No. About Company Business: Montes Archimedes Acquisition Corp is a shell company with a Special Purpose Acquisition Company with a focus on the health care industry. and certain other persons party thereto.įorm of Lock-Up Agreement, dated as of June 9, 2021, by and among Roivant Sciences Ltd. Company Website: MONTES ARCHIMEDES ACQUISITION CORP. 1 to the Sponsor Support Agreement, dated as of June 9, 2021, by and among Patient Square Capital LLC, Montes Archimedes Acquisition Corp, Roivant Sciences Ltd. (the ?Company?) in connection with the proposed transactĪmendment No. Upon closing of the transaction, outstanding shares and warrants of MAAC will be exchanged for newly issued shares. (Nasdaq: MAAC), today announced that they have entered into a definitive business combination agreement. (MAAC) is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange. Montes Archimedes Acquisition Corp Cl A stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Roivant Overview June 2021 Statement of Limitations (1/2) This investor presentation (this ?Presentation?) was prepared by Montes Archimedes Acquisition Corp. Roivant Sciences, a biopharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. About Montes Archimedes Acquisition Corp.
![montes archimedes acquisition corp montes archimedes acquisition corp](https://sec.report/Document/0001104659-21-085475/tm2119232d5_ex99-1img024.jpg)
![montes archimedes acquisition corp montes archimedes acquisition corp](https://wvhistoryonview.org/image/034771.jpg)
The SPAC sustained redemptions of 38,400,312 shares, wiping out about 93.5 of its cash in trust. 2 to the Sponsor Support Agreement, dated as of September 30, 2021, among Roivant, MAAC, MAAC Sponsor and the other parties thereto Montes Archimedes Acquisition in an 8-K filing said stockholders voted in favor of combining with with biopharmaceutical and healthcare technology company Roivant Sciences.